Absorbable tissue expander

• US 6,206,930 B1
• Filed: 08/10/1998
• Issued: 03/27/2001
• Est. Priority Date: 08/10/1998
• Status: Expired due to Fees

• Current Assignee: Charlotte Mecklenburg Hospital Authority
• Original Assignee: Charlotte Mecklenburg Hospital Authority
• Inventors: Burg, Karen J. L., Halberstadt, Craig Reed, Holder, Walter Dalton Jr.
• Primary Examiner(s): Milano, Michael J.
• Application Number:
  US09/131,470
• Time in Patent Office: 960 Days
• Field of Search: 623/8, 623/11, 623/12, 623/66, 623/23.64, 606/191, 606/194, 606/195, 604/96, 604/101
• US Class Current: 623/23.64
• CPC Class Codes: A61F 2/0063 Implantable repair or support meshes, e.g. hernia meshes
• CPC Class Codes: A61F 2/02 Prostheses implantable into the body closure means for urethra or rectum or for artificial body openings therefor A61F2/0004

Abstract

The invention relates to an absorbable implantable tissue expander device that can be used in surgeries as a gradually diminishing space filler. The absorbable tissue expander has a fluid-tight or semipermeable envelope having a bio-absorbable biocompatible shell defining a chamber. The envelope is inflatable upon infusion of a fluid into the chamber and deflatable upon removal of the fluid from the chamber. The tissue expander also enables the controlled inflation and deflation of the envelope after the device is implanted in a tissue.

Claims

1. A tissue expander comprising:

a fluid-tight or semipermeable envelope having a bio-absorbable biocompatible shell defining a chamber having a predefined bio-absorption rate, said envelope being inflatable upon infusion of a fluid or a gel into said chamber and deflatable upon removal of fluid or gel from said chamber;

means for controlled inflation of said envelope after said tissue expander is implanted in a tissue; and

means for controlled deflation of said envelope after inflation in said tissue without removing said tissue expander from said tissue other than by degradation in situ.

2. The tissue expander of claim 1, wherein said shell is made of a material selected from the group consisting of polyesters, polyanhydrides, polyphosphazenes, polyorthoesters, polyoxalates, polyetheresters, polycarbonates, polycaprolactone, polylactide, copolymer of polylactide and ε

-caprolactone, elastomeric polypeptides, mixtures thereof, and composites thereof.

3. The tissue expander of claim 1, wherein said shell is made of polylactide or a lactide/ε

-caprolactone copolymer.

4. The tissue expander of claim 1, wherein said shell is capable of being completely absorbed in tissue within a time period of from about 1 month to about 2 years.

5. The tissue expander of claim 1, wherein said shell is capable of being completely absorbed in tissue within a time period of from about 3 months to about 1 year.

6. The tissue expander of claim 1, wherein said means for controlled inflation and deflation of said envelope includes an injection port having a hollow region which is in fluid communication with the interior of said chamber.

7. The tissue expander of claim 1, wherein said fluid or gel further includes a signal selected from the group consisting of cytokines, growth factors, antineoplastic, chemotherapy agents, and adhesion preventing agents.

8. A tissue expander comprising:

a plurality of fluid-tight or semipermeable envelopes, each envelope comprising a chamber defined by a bio-absorbable biocompatible shell having a predefined bio-absorption rate and being inflatable upon infusion of a fluid or a gel, and deflatable upon removal of said fluid or said gel from said chamber, wherein each envelope shares a portion of its shell with another envelope; and

means for the controlled inflation and deflation of said envelopes after said expander is implanted in a tissue.

9. The tissue expander according to claim 8, wherein said means comprises a plurality of injection ports each of which has a hollow region which is in fluid communication with the interior of a chamber.

10. The tissue expander according to claim 8, wherein each envelope has a pre-defined bio-absorption rate in the tissue and bio-absorption rate of one envelope is not dependent on the bio-absorption rate of another envelope.

11. The tissue expander according to claim 8, wherein said shells are made of a material selected from the group consisting of polyesters, polyanhydrides, polyphosphazenes, polyorthoesters, polyoxalates, polyetheresters, polycarbonates, polycaprolactone, polylactide, copolymer of polylactide and ε

-caprolactone, elastomeric polypeptides, mixtures thereof, and composites thereof.

12. The tissue expander according to claim 8, wherein said shells are made of polylactide or lactide/ε

-caprolactone copolymer.